<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34804036</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Changes in MDA5 and TLR3 Sensing of the Same Diabetogenic Virus Result in Different Autoimmune Disease Outcomes.</ArticleTitle><Pagination><StartPage>751341</StartPage><MedlinePgn>751341</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">751341</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2021.751341</ELocationID><Abstract><AbstractText>Seemingly redundant in function, melanoma differentiation-associated protein 5 (MDA5) and toll-like receptor- 3 (TLR3) both sense RNA viruses and induce type I interferon (IFN-I). Herein, we demonstrate that changes in sensing of the same virus by MDA5 and TLR3 can lead to distinct signatures of IFN-&#x3b1; and IFN-&#xdf; resulting in different disease outcomes. Specifically, infection with a diabetogenic islet &#x3b2; cell-tropic strain of coxsackievirus (CB4) results in diabetes protection under reduced MDA5 signaling conditions while reduced TLR3 function retains diabetes susceptibility. Regulating the induction of IFN-I at the site of virus infection creates a local site of interferonopathy leading to loss of T cell regulation and induction of autoimmune diabetes. We have not demonstrated another way to prevent T1D in the NOD mouse, rather we believe this work has provided compounding evidence for a specific control of IFN-I to drive a myriad of responses ranging from virus clearance to onset of autoimmune diabetes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Lincez, Shanina and Horwitz.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lincez</LastName><ForeName>Pamela J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Michael Smith Laboratories, The University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shanina</LastName><ForeName>Iryna</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Immunology, Life Sciences Institute, The University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horwitz</LastName><ForeName>Marc S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Microbiology &amp; Immunology, Life Sciences Institute, The University of British Columbia, Vancouver, BC, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C519703">TLR3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051196">Toll-Like Receptor 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C510592">Ifih1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D000072640">Interferon-Induced Helicase, IFIH1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="N">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003922" MajorTopicYN="N">Diabetes Mellitus, Type 1</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072640" MajorTopicYN="N">Interferon-Induced Helicase, IFIH1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016688" MajorTopicYN="N">Mice, Inbred NOD</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051196" MajorTopicYN="N">Toll-Like Receptor 3</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MDA5</Keyword><Keyword MajorTopicYN="N">TLR3</Keyword><Keyword MajorTopicYN="N">autoimmunity</Keyword><Keyword MajorTopicYN="N">coxsackievirus</Keyword><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">interferon</Keyword><Keyword MajorTopicYN="N">interferonopathy</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>22</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34804036</ArticleId><ArticleId IdType="pmc">PMC8602094</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2021.751341</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blum SI, Tse HM. Innate Viral Sensor MDA5 and Coxsackievirus Interplay in Type 1 Diabetes Development. Microorganisms (2020) 8:1&#x2013;23. doi:&#xa0;10.3390/microorganisms8070993</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8070993</ArticleId><ArticleId IdType="pmc">PMC7409145</ArticleId><ArticleId IdType="pubmed">32635205</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson SJ, Horwitz MS. Is Type 1 Diabetes &#x201c;Going Viral&#x201d;? Diabetes (2014) 63:2203&#x2013;05. doi: 10.2337/db14-0510</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db14-0510</ArticleId><ArticleId IdType="pubmed">24962917</ArticleId></ArticleIdList></Reference><Reference><Citation>Morse ZJ, Horwitz MS. Innate Viral Receptor Signaling Determines Type 1 Diabetes Onset. Front Endocrinol (2017) 8:249. doi: 10.3389/fendo.2017.00249</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2017.00249</ArticleId><ArticleId IdType="pmc">PMC5623193</ArticleId><ArticleId IdType="pubmed">29018409</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson SJ, Morgan NG. Enteroviral Infections in the Pathogenesis of Type 1 Diabetes: New Insights for Therapeutic Intervention. Curr Opin Pharmacol (2018) 43:11&#x2013;19. doi: 10.1016/j.coph.2018.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2018.07.006</ArticleId><ArticleId IdType="pmc">PMC6294842</ArticleId><ArticleId IdType="pubmed">30064099</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Calvo T, Richardson SJ, Pugliese A. Pancreas Pathology During the Natural History of Type 1 Diabetes. Curr Diabetes Rep (2018) 18:1&#x2013;12. doi: 10.1007/s11892-018-1084-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-018-1084-3</ArticleId><ArticleId IdType="pubmed">30293191</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira RC, Guo H, Coulson RMR, Smyth DJ, Pekalski ML, Burren OS, et al. . A Type I Interferon Transcriptional Signature Precedes Autoimmunity in Children Genetically at Risk for Type 1 Diabetes. Diabetes (2014) 63:2538&#x2013;50. doi:&#xa0;10.2337/db13-1777</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db13-1777</ArticleId><ArticleId IdType="pmc">PMC4066333</ArticleId><ArticleId IdType="pubmed">24561305</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundberg M, Krogvold L, Kuric E, Dahl-J&#xf8;rgensen K, Skog O. Expression of Interferon-Stimulated Genes in Insulitic Pancreatic Islets of Patients Recently Diagnosed With Type 1 Diabetes. Diabetes (2016) 65:3104&#x2013;10. doi:&#xa0;10.2337/db16-0616</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db16-0616</ArticleId><ArticleId IdType="pubmed">27422384</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafavi S, Yoshida H, Moodley D, LeBoit&#xe9; H, Rothamel K, Raj T, et al. . Parsing the Interferon Transcriptional Network and Its Disease Associations. Cell (2016) 164:564&#x2013;78. doi:&#xa0;10.1016/j.cell.2015.12.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.12.032</ArticleId><ArticleId IdType="pmc">PMC4743492</ArticleId><ArticleId IdType="pubmed">26824662</ArticleId></ArticleIdList></Reference><Reference><Citation>Poma AM, Genoni A, Broccolo F, Denaro M, Pugliese A, Basolo F, et al. . Immune Transcriptome of Cells Infected With Enterovirus Strains Obtained From Cases of Type 1 Diabetes. Microorganisms (2020) 8:1&#x2013;16. doi:&#xa0;10.3390/microorganisms8071031</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8071031</ArticleId><ArticleId IdType="pmc">PMC7409211</ArticleId><ArticleId IdType="pubmed">32664675</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvennick N. Diabetes Induced by Coxsackie Virus: Initiation by Bystander Damage and Not Molecular Mimicry. Nat Med (1998) 4:781&#x2013;5. doi:&#xa0;10.1038/nm0798-781</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0798-781</ArticleId><ArticleId IdType="pubmed">9662368</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JP, Cerny A, Asher DR, Kurt-Jones EA, Bronson RT, Finberg RW. MDA5 and MAVS Mediate Type I Interferon Responses to Coxsackie B Virus. J Virol (2010) 84:254&#x2013;60. doi:&#xa0;10.1128/JVI.00631-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00631-09</ArticleId><ArticleId IdType="pmc">PMC2798442</ArticleId><ArticleId IdType="pubmed">19846534</ArticleId></ArticleIdList></Reference><Reference><Citation>Richer MJ, Lavall&#xe9;e DJ, Shanina I, Horwitz MS. Toll-Like Receptor 3 Signalling on Macrophages Is Required for Survival Following Coxsackievirus B4 Infection. PLoS One (2009) 4:e4127. doi:&#xa0;10.1371/journal.pone.0004127</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0004127</ArticleId><ArticleId IdType="pmc">PMC2606033</ArticleId><ArticleId IdType="pubmed">19122812</ArticleId></ArticleIdList></Reference><Reference><Citation>Lincez PJ, Shanina I, Horwitz MS. Reduced Expression of the MDA5 Gene IFIH1 Prevents Autoimmune Diabetes. Diabetes (2015) 64:2184&#x2013;93. doi:&#xa0;10.2337/db14-1223</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db14-1223</ArticleId><ArticleId IdType="pubmed">25591872</ArticleId></ArticleIdList></Reference><Reference><Citation>Swiecki M, McCartney SA, Wang Y, Colonna M. TLR7/9 Versus TLR3/MDA5 Signaling During Virus Infections and Diabetes. J Leukoc Biol (2011) 90:691&#x2013;701. doi:&#xa0;10.1189/jlb.0311166</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0311166</ArticleId><ArticleId IdType="pmc">PMC3177694</ArticleId><ArticleId IdType="pubmed">21844166</ArticleId></ArticleIdList></Reference><Reference><Citation>McCartney SA, Vermi W, Lonardi S, Rossini C, Otero K, Calderon B, et al. . RNA Sensor-Induced Type I IFN Prevents Diabetes Caused by A ?? Cell-Tropic Virus in Mice. J Clin Invest (2011) 121:1497&#x2013;507. doi:&#xa0;10.1172/JCI44005</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI44005</ArticleId><ArticleId IdType="pmc">PMC3069767</ArticleId><ArticleId IdType="pubmed">21403398</ArticleId></ArticleIdList></Reference><Reference><Citation>Marro BS, Ware BC, Zak J, de la Torre JC, Rosen H, Oldstone MBA. Progression of Type 1 Diabetes From the Prediabetic Stage Is Controlled by Interferon-&#x3b1; Signaling. Proc Natl Acad Sci USA (2017) 114:3708&#x2013;13. doi:&#xa0;10.1073/pnas.1700878114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1700878114</ArticleId><ArticleId IdType="pmc">PMC5389329</ArticleId><ArticleId IdType="pubmed">28325871</ArticleId></ArticleIdList></Reference><Reference><Citation>De Beeck AO, Eizirik DL. Viral Infections in Type 1 Diabetes Mellitus-Why the &#x3b2; Cells? Nat Rev Endocrinol (2016) 12:263&#x2013;73. doi: 10.1038/nrendo.2016.30</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2016.30</ArticleId><ArticleId IdType="pmc">PMC5348720</ArticleId><ArticleId IdType="pubmed">27020257</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmittgen TD, Livak KJ. Analyzing Real-Time PCR Data by the Comparative CT Method. Nat Protoc (2008) 3:1101&#x2013;8. doi:&#xa0;10.1038/nprot.2008.73</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2008.73</ArticleId><ArticleId IdType="pubmed">18546601</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz MS, Ilic A, Fine C, Rodriguez E, Sarvetnick N. Presented Antigen From Damaged Pancreatic ?? Cells Activates Autoreactive T Cells in Virus-Mediated Autoimmune Diabetes. J Clin Invest (2002) 109:79&#x2013;87. doi:&#xa0;10.1172/JCI200211198</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI200211198</ArticleId><ArticleId IdType="pmc">PMC150813</ArticleId><ArticleId IdType="pubmed">11781353</ArticleId></ArticleIdList></Reference><Reference><Citation>Flodstr&#xf6;m M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N. Target Cell Defense Prevents the Development of Diabetes After Viral Infection. Nat Immunol (2002) 3:373&#x2013;82. doi:&#xa0;10.1038/ni771</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni771</ArticleId><ArticleId IdType="pubmed">11919579</ArticleId></ArticleIdList></Reference><Reference><Citation>Chehadeh W, Kerr-Conte J, Pattou F, Alm G, Lefebvre J, Wattr&#xe9; P, et al. . Persistent Infection of Human Pancreatic Islets by Coxsackievirus B Is Associated With Alpha Interferon Synthesis in &#x3b2; Cells. J Virol (2000) 74:10153&#x2013;64. doi:&#xa0;10.1128/jvi.74.21.10153-10164.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.21.10153-10164.2000</ArticleId><ArticleId IdType="pmc">PMC102054</ArticleId><ArticleId IdType="pubmed">11024144</ArticleId></ArticleIdList></Reference><Reference><Citation>Serreze DV, Hamaguchi K, Leiter EH. Immunostimulation Circumvents Diabetes in NOD/Lt Mice. J Autoimmun (1989) 2:759&#x2013;76. doi:&#xa0;10.1016/0896-8411(89)90003-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-8411(89)90003-6</ArticleId><ArticleId IdType="pubmed">2533502</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobel DO, Goyal D, Ahvazi B, Yoon JW, Chung YH, Bagg A, et al. . Low Dose Poly I:C Prevents Diabetes in the Diabetes Prone BB Rat. J Autoimmun (1998) 11:343&#x2013;52. doi:&#xa0;10.1006/jaut.1998.0203</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jaut.1998.0203</ArticleId><ArticleId IdType="pubmed">9776712</ArticleId></ArticleIdList></Reference><Reference><Citation>Devendra B, Jasinski J, Melanitou E, Nakayama M, Li M, Hensley B, et al. . Interferon-&#x3b1; as a Mediator of Polyinosinic : Polycytidylic Acid-Induced Type 1 Diabetes. Diabetes (2005) 54:2549&#x2013;56. doi:&#xa0;10.2337/diabetes.54.9.2549</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.54.9.2549</ArticleId><ArticleId IdType="pubmed">16123342</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>